Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma is a research paper published in Cancers (2021). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: T32 GM007347, F30 CA216891-01, F30 CA224559, F30 CA225136-01, K12 CA090625, 5P30 CA068485-21, 2P50 CA098131-11
U.S. Department of Defense
Grant: W81XWH-18-2-0052
NIGMS NIH HHS
Grant: T32 GM152284
NIDDK NIH HHS
Grant: T32 DK101003
NCI NIH HHS
Grant: K12 CA090625
NIGMS NIH HHS
Grant: T32 GM007347
NCI NIH HHS
Grant: R01 CA217987
NIH HHS
Grant: S10 OD016355
FWCI
1.43
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals